AKBA
Akebia Therapeutics Inc
Price:  
3.62 
USD
Volume:  
1,565,452.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AKBA Fair Value

-163.81 %
Upside

What is the fair value of AKBA?

As of 2025-07-07, the Fair Value of Akebia Therapeutics Inc (AKBA) is -2.31 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.62 USD, the upside of Akebia Therapeutics Inc is -163.81%.

Is AKBA a good investment?

With the market price of 3.62 USD and our fair value calculation, Akebia Therapeutics Inc (AKBA) is not a good investment. Investing in AKBA stocks now will result in a potential loss of 163.81%.

Note: valuation result may not be accurate due to the company's negative EPS.

3.62 USD
Stock Price
-2.31 USD
Fair Price
FAIR VALUE CALCULATION

AKBA Fair Value

Peter Lynch's formula is:

AKBA Fair Value
= Earnings Growth Rate x TTM EPS
AKBA Fair Value
= 13.39 x -0.17
AKBA Fair Value
= -2.31

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -384.80 -282.00 -94.20 -51.92 -69.41 -176.47
YoY growth -37.58% 26.72% 66.60% 44.88% -33.67% 13.39%

AKBA Fair Value - Key Data

Market Cap (mil) 950.76
P/E
Forward P/E
EPS -0.17
Avg earnings growth rate 13.39%
TTM earnings -45.31